Skip to main content
MedPathMedPath Home
Clinical Trials/JPRN-UMIN000025911
JPRN-UMIN000025911
Completed
未知

A prospective study of magnetic resonance imaging and ultrasonography (MRI/US)-fusion targeted biopsy and concurrent systematic biopsy with the average of 18-cores to detect clinically significant prostate cancer - A prospective study of magnetic resonance imaging and ultrasonography (MRI/US)-fusion targeted biopsy and concurrent systematic biopsy with the average of 18-cores to detect clinically significant prostate cancer

Tokyo Metropolitan Police Hospital0 sites150 target enrollmentJanuary 30, 2017
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Tokyo Metropolitan Police Hospital
Enrollment
150
Status
Completed
Last Updated
2 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
January 30, 2017
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
Male

Investigators

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • •Patients who MRI/US fusion\-targeted and concurrent systematic biopsies were not performed

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
Not Applicable
Prospective study on magnetic resonance tomography (MRI) -based molecular liver parenchyma diagnosticsK74Fibrosis and cirrhosis of liver
DRKS00012564niversity Hospital Regensburg100
Not yet recruiting
Not Applicable
A study of Magnetic Resonance Imaging(MRI) evaluation in knee joint pathologies.
CTRI/2018/05/013938Department of Radiodiagnosis Government Medical College and Sir T HospitalBhavnagar
Active, not recruiting
Phase 1
Magnetic Resonance Imaging (MRI) Assessments of the Heart and Liver Iron Load in Patients With Transfusion Induced Iron OverloadMedDRA version: 19.0Level: LLTClassification code 10028534Term: Myelodysplastic syndrome NOSSystem Organ Class: 100000004864Therapeutic area: Diseases [C] - Blood and lymphatic diseases [C15]
EUCTR2016-000246-62-Outside-EU/EEAovartis53
Not yet recruiting
Not Applicable
Evaluating the use of Magnetic Resonance Imaging and Contrast Enhanced Mammography after MagTrace® usebreast cancermammacarcinoma10006291
NL-OMON51366Zuyderland Medisch Centrum40
Completed
Not Applicable
Predictive value of Magnetic Resonance Imaging (MRI), positron emission tomography (PET), and microemboli detection for stroke
NL-OMON31611Academisch Medisch Centrum278